Taking advantage of this well-described skeletal muscle cell model, in the present work we generated an A-T cellular model using USCs knocked out for ATM by CRISPR/Cas9 technology and differentiated them into skeletal muscle cells providing a useful platform for studying the molecular mechanism underlying the ataxia-telangiectasia phenotype. This evidence concerns the gene ATM and ataxia telangiectasia.